...
机译:成功的分子靶向治疗AML AML妊娠中的AML AML,含氮杂氨酸和索拉非苯胺,没有不良胎儿结果
Department of HaematologyUniversity Hospital of WalesCardiff UK;
Department of HaematologyUniversity Hospital of WalesCardiff UK;
Regional Neonatal Intensive Care UnitUniversity Hospital of WalesCardiff UK;
Department of Obstetrics and GynaecologyUniversity Hospital of WalesCardiff UK;
Department of Obstetrics and GynaecologyUniversity Hospital of WalesCardiff UK;
Department of HaematologyUniversity Hospital of WalesCardiff UK;
Department of HaematologyUniversity Hospital of WalesCardiff UK;
Department of HaematologyUniversity Hospital of WalesCardiff UK;
leukaemia; pregnancy; acute leukaemia;
机译:成功的分子靶向治疗AML AML妊娠中的AML AML,含氮杂氨酸和索拉非苯胺,没有不良胎儿结果
机译:3-药物组合治疗Art838,ABT199加索氮对AML异种移植物有效,可能通过MCL1的合作靶向
机译:1B阶段1B剂量升级Bi 8(3)68(5)8和偶氮辛胺在以前未经处理的AML中的α:结果来自BEGE AML S-2
机译:出生于布拉德福德的出生队列中,怀孕期间饮用水中三卤甲烷的暴露以及不利的胎儿生长结果的风险
机译:孕妇在怀孕期间使用选择性5-羟色胺再摄取抑制剂与不良妊娠结局之间的关联。
机译:悬浮剂治疗后用阿扎胞苷成功治疗从MDS转化为低原始计数的AML患者
机译:用氮杂氨酸和索拉非尼对妊娠的成功分子靶向治疗AML,没有不良胎儿结果